A Comparison of Oral Dydrogesterone with Vaginal Progesterone for Luteal-Phase Support in
Dydrogesterone
fertilization in vitro
infertility
luteal phase
progesterone
Journal
Advanced biomedical research
ISSN: 2277-9175
Titre abrégé: Adv Biomed Res
Pays: India
ID NLM: 101586897
Informations de publication
Date de publication:
2023
2023
Historique:
received:
30
07
2022
revised:
21
11
2022
accepted:
26
11
2022
medline:
12
7
2023
pubmed:
12
7
2023
entrez:
12
7
2023
Statut:
epublish
Résumé
The quality of the luteal phase is the most important issue affecting pregnancy outcomes in assisted reproductive technology (ART). Luteal-phase support with the administration of gonadotropin-releasing hormone (GnRH) agonist or progesterone improves the likelihood of pregnancy in ART. Due to disagreements regarding the best pharmaceutical form of progesterone for success of This unblinded randomized clinical trial was conducted at the Shahid Beheshti Hospital, Obstetrics and Gynecology Centre in Isfahan, Iran, between june 2021 and September 2021. In total, 126 couples were included in the study. All patients underwent controlled ovarian stimulation and IVF. Patients were randomly divided into two groups ( No significant differences were observed between the two groups in terms of the mean endometrial thickness ( The evidence from this study indicates that Duphaston is as effective as Cyclogest for luteal-phase support.
Sections du résumé
Background
UNASSIGNED
The quality of the luteal phase is the most important issue affecting pregnancy outcomes in assisted reproductive technology (ART). Luteal-phase support with the administration of gonadotropin-releasing hormone (GnRH) agonist or progesterone improves the likelihood of pregnancy in ART. Due to disagreements regarding the best pharmaceutical form of progesterone for success of
Materials and Methods
UNASSIGNED
This unblinded randomized clinical trial was conducted at the Shahid Beheshti Hospital, Obstetrics and Gynecology Centre in Isfahan, Iran, between june 2021 and September 2021. In total, 126 couples were included in the study. All patients underwent controlled ovarian stimulation and IVF. Patients were randomly divided into two groups (
Results
UNASSIGNED
No significant differences were observed between the two groups in terms of the mean endometrial thickness (
Conclusions
UNASSIGNED
The evidence from this study indicates that Duphaston is as effective as Cyclogest for luteal-phase support.
Identifiants
pubmed: 37434944
doi: 10.4103/abr.abr_253_22
pii: ABR-12-132
pmc: PMC10331522
doi:
Types de publication
Journal Article
Langues
eng
Pagination
132Informations de copyright
Copyright: © 2023 Advanced Biomedical Research.
Déclaration de conflit d'intérêts
There are no conflicts of interest.
Références
JBRA Assist Reprod. 2018 Jun 01;22(2):148-156
pubmed: 29488367
Cochrane Database Syst Rev. 2011 Oct 05;(10):CD009154
pubmed: 21975790
Int J Fertil Steril. 2016 Jul-Sep;10(2):162-8
pubmed: 27441048
Cochrane Database Syst Rev. 2015 Jul 07;(7):CD009154
pubmed: 26148507
Arch Gynecol Obstet. 2019 Jun;299(6):1727-1736
pubmed: 30955059
Horm Mol Biol Clin Investig. 2016 Aug 1;27(2):55-62
pubmed: 26677905
J Gynecol Obstet Hum Reprod. 2018 Dec;47(10):533-537
pubmed: 29783035
Iran J Reprod Med. 2013 Nov;11(11):913-8
pubmed: 24639716
PLoS One. 2020 Nov 4;15(11):e0241044
pubmed: 33147288
Fertil Steril. 2018 May;109(5):756-762
pubmed: 29778368
Gynecol Endocrinol. 2016 Aug;32(8):667-671
pubmed: 26950060
J Obstet Gynaecol Res. 2019 Apr;45(4):794-802
pubmed: 30632226
Iran J Reprod Med. 2015 Jul;13(7):433-8
pubmed: 26494991
Fertil Steril. 2017 Mar;107(3):749-755
pubmed: 28065408
Panminerva Med. 2019 Mar;61(1):1-2
pubmed: 30674179
Acta Obstet Gynecol Scand. 2019 Oct;98(10):1318-1325
pubmed: 31087325
Singapore Med J. 2017 Jun;58(6):294-297
pubmed: 27090598
Gynecol Endocrinol. 2020 May;36(5):389-397
pubmed: 32054365
Hum Reprod. 2017 May 1;32(5):1019-1027
pubmed: 28333318
Fertil Steril. 2011 May;95(6):1961-5
pubmed: 21333984
Gynecol Endocrinol. 2016;32(3):213-7
pubmed: 26486011